Roadmap for a precision-medicine initiative in the Nordic region

Pål Rasmus Njølstad, Ole Andreas Andreassen, Søren Brunak, Anders D. Børglum, Joakim Dillner, Tõnu Esko, Paul W. Franks, Nelson Freimer, Leif Groop, Hakon Heimer, David M. Hougaard, Eivind Hovig, Kristian Hveem, Anu Jalanko, Jaakko Kaprio, Gun Peggy Knudsen, Mads Melbye, Andres Metspalu, Preben Bo Mortensen, Juni PalmgrenAarno Palotie, Wenche Reed, Hreinn Stefánsson, Nathan O. Stitziel, Patrick F. Sullivan, Unnur Thorsteinsdóttir, Marc Vaudel, Eero Vuorio, Thomas Werge, Camilla Stoltenberg, Kári Stefánsson

Research output: Contribution to journalComment/debate

19 Scopus citations


The Nordic region, comprising primarily Denmark, Estonia, Finland, Iceland, Norway and Sweden, has many of the necessary characteristics for being at the forefront of genome-based precision medicine. These include egalitarian and universal healthcare, expertly curated patient and population registries, biobanks, large population-based prospective cohorts linked to registries and biobanks, and a widely embraced sense of social responsibility that motivates public engagement in biomedical research. However, genome-based precision medicine can be achieved only through coordinated action involving all actors in the healthcare sector. Now is an opportune time to organize scientists in the Nordic region, together with other stakeholders including patient representatives, governments, pharmaceutical companies, academic institutions and funding agencies, to initiate a Nordic Precision Medicine Initiative. We present a roadmap for how this organization can be created. The Initiative should facilitate research, clinical trials and knowledge transfer to meet regional and global health challenges.

Original languageEnglish
Pages (from-to)924-930
Number of pages7
JournalNature Genetics
Issue number6
StatePublished - Jun 1 2019


Dive into the research topics of 'Roadmap for a precision-medicine initiative in the Nordic region'. Together they form a unique fingerprint.

Cite this